Effect of Dapagliflozin on Myocardial Insulin Sensitivity and Perfusion: Rationale and Design of The DAPAHEART Trial
media
posted on 2021-05-21, 09:40 authored by Adis journals on behalf of:, Gian Pio Sorice, Francesca Cinti, Lucia Leccisotti, Domenico D’Amario, Margherita Lorusso, Maria Angela Guzzardi, Teresa Mezza, Camilla Cocchi, Umberto Capece, Pietro Manuel Ferraro, Filippo Crea, Alessandro Giordano, Patricia Iozzo, Andrea Giaccari<p><strong>Article full
text</strong></p>
<p> </p>
<p><br></p>
<p> </p>
<p>The above summary slide represents
the opinions of the authors. For a full list of declarations, including funding
and author disclosure statements, please see the full text online (see “read
the peer-reviewed publication” opposite). </p>
<p>© The authors, CC-BY-NC 2021.</p>
<p> </p>
History
Related Materials
- 1.
- 2.
